Effect of Lactobacillus rhamnosus LGG® and Bifidobacterium animalis ssp. lactis BB-12® on health-related quality of life in college students affected by upper respiratory infections

British Journal of Nutrition

Volumn 109, Issue 11, 2013, Pages 1999-2007

  Smith, Tracey J ^a   Rigassio Radler, Diane ^a   Denmark, Robert ^a   Haley, Timothy ^a,b   Touger Decker, Riva ^a  

^a UNIVERSITY OF MEDICINE AND DENTISTRY OF NEW JERSEY   (United States)

^b U S ARMY RESEARCH INSTITUTE OF ENVIRONMENTAL MEDICINE   (United States)

Author keywords

Bifidobacterium; Common cold; Lactobacillus; Probiotics; Respiratory tract infections

Indexed keywords

PLACEBO; PROBIOTIC AGENT;

ABSENTEEISM; ADULT; ARTICLE; BIFIDOBACTERIUM ANIMALIS; COLLEGE STUDENT; COLONY FORMING UNIT; CONTROLLED STUDY; DISEASE DURATION; DISEASE PREDISPOSITION; DISEASE SEVERITY; DOUBLE BLIND PROCEDURE; DRUG EFFECT; FEMALE; FUNCTIONAL DISEASE; HEALTH SURVEY; HUMAN; LACTOBACILLUS RHAMNOSUS; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; SELF REPORT; TREATMENT DURATION; UPPER RESPIRATORY TRACT INFECTION;

ADOLESCENT; BIFIDOBACTERIUM; DOUBLE-BLIND METHOD; FEMALE; HUMANS; LACTOBACILLUS RHAMNOSUS; MALE; PROBIOTICS; QUALITY OF LIFE; RESPIRATORY TRACT INFECTIONS; STUDENTS; UNIVERSITIES; YOUNG ADULT;

EID: 84877952654     PISSN: 00071145     EISSN: 14752662     Source Type: Journal    
DOI: 10.1017/S0007114512004138     Document Type: Article

References (50)

1. Cohen S, Doyle WJ, Alper CM, et al. (2009) Sleep habits and susceptibility to the common cold. Arch Intern Med 169, 62-67.
2. American College Health Association (2009) American College Health Association-National College Health Assessment II: Reference Group Executive Summary Spring 2009 Report. Linthicum, MD: American College Health Association.
3. Adams TB, Wharton CM, Quilter L, et al. (2008) The association between mental health and acute infectious illness among a national sample of 18-to 24-year-old college students. J Am Coll Health 56, 657-663.
4. Segerstrom SC & Miller GE (2004) Psychological stress and the human immune system: a meta-analytic study of 30 years of inquiry. Psychol Bull 130, 601-630.
5. White C, Kolble R, Carlson R, et al. (2005) The impact of a health campaign on hand hygiene and upper respiratory illness among college students living in residence halls. J Am Coll Health 53, 175-181.
6. Nichol KL, D'Heilly S & Ehlinger E (2005) Colds and influenza-like illnesses in university students: impact on health, academic and work performance, and health care use. Clin Infect Dis 40, 1263-1270.
7. Nichol KL, D'Heilly S & Ehlinger E (2006) Burden of upper respiratory illnesses among college and university students: 2002-2003 and 2003-2004 cohorts. Vaccine 24, 6724-6725.
8. American College Health Association (2009) American College Health Association-National College Health Assessment Spring 2008 Reference Group Data Report (Abridged). J Am Coll Health 57, 477-488.
9. Bolser DC (2006) Cough suppressant and pharmacologic protussive therapy: ACCP evidence-based clinical practice guidelines. Chest 129, 238S-249S.
10. Smith SM, Schroeder K & Fahey T (2008) Over-the-counter medications for acute cough in children and adults in ambulatory settings. The Cochrane Database of Systematic Reviews, CD001831.
11. Sutter AI, Lemiengre M, Campbell H, et al. (2003) Antihista-mines for the common cold. The Cochrane Database of Systematic Reviews, CD001267.
12. Taverner D & Latte J (2007) Nasal decongestants for the common cold. The Cochrane Database of Systematic Reviews, CD001953.
13. Wilson IB & Cleary PD (1995) Linking clinical variables with health-related quality of life. A conceptual model of patient outcomes. JAMA 273, 59-65.
14. Barrett B, Locken K, Maberry R, et al. (2002) The Wisconsin Upper Respiratory Symptom Survey (WURSS): a new research instrument for assessing the common cold. J Fam Prac 51, 265.
15. Juniper EF (1997) Measuring health-related quality of life in rhinitis. J Allergy Clin Immunol 99, S742-S749.
16. Linder JA & Singer DE (2003) Health-related quality of life of adults with upper respiratory tract infections. J Gen Intern Med 18, 802-807.
17. World Health Organization (2002) Guidelines for the evaluation of probiotics in food. In Joint FAO/WHO Working Group Meeting, pp. 1-11. Geneva: World Health Organization.
18. w in an influenza vaccination model: a randomised, double-blind, placebo-controlled study. Br J Nutr 107, 876-884.
19. Link-Amster H, Rochat F, Saudan KY, et al. (1994) Modulation of a specific humoral immune response and changes in intestinal flora mediated through fermented milk intake. FEMS Immunol Med Microbiol 10, 55-63.
20. Schiffrin EJ, Rochat F, Link-Amster H, et al. (1995) Immunomodulation of human blood cells following the ingestion of lactic acid bacteria. J Dairy Sci 78, 491-497.
21. Schiffrin EJ, Brassart D, Servin AL, et al. (1997) Immune modulation of blood leukocytes in humans by lactic acid bacteria: criteria for strain selection. Am J Clin Nutr 66, 515S-520S.
22. de Vrese M, Rautenberg P, Laue C, et al. (2005) Probiotic bacteria stimulate virus-specific neutralizing antibodies following a booster polio vaccination. Eur J Nutr 44, 406-413.
23. Christensen HR, Larsen CN, Kaestel P, et al. (2006) Immuno-modulating potential of supplementation with probiotics: a dose-response study in healthy young adults. FEMS Immunol Med Microbiol 47, 380-390.
24. Berggren A, Lazou Ahrén I, Larsson N, et al. (2011) Randomised, double-blind and placebo-controlled study using new probiotic lactobacilli for strengthening the body immune defence against viral infections. Eur J Nutr 50, 203-210.
25. Gleeson M, Bishop NC, Oliveira M, et al. (2011) Daily pro-biotic's (Lactobacillus casei Shirota) reduction of infection incidence in athletes. Int J Sport Nutr Exerc Metab 21, 55-64.
26. Kirchberger S, Majdic O & Stockl J (2007) Modulation of the immune system by human rhinoviruses. Int Arch Allergy Immunol 142, 1-10.
27. Hatakka K, Savilahti E, Ponka A, et al. (2001) Effect of long term consumption of probiotic milk on infections in children attending day care centres: double blind, randomised trial. Br Med J 322, 1327.
28. Taipale T, Pienihakkinen K, Isolauri E, et al. (2011) Bifido-bacterium animalis subsp. lactis BB-12 in reducing the risk of infections in infancy. Br J Nutr 105, 409-416.
29. Rautava SE, Salminen S & Isolauri E (2009) Specific probio-tics in reducing the risk of acute infections in infancy-a randomised, double-blind, placebo-controlled study. Br J Nutr 101, 1722-1726.
30. Barrett B, Brown RL, Mundt MP, et al. (2009) Validation of a short form Wisconsin Upper Respiratory Symptom Survey (WURSS-21). Health Qual Life Outcomes 7, 76-96.
31. National Institutes of Health. (2006) National Institutes of Health Policy on Reporting Race and Ethnicity Data: Subjects in Clinical Research. http://grants.nih.gov/grants/guide/notice-files/not-od-01-053.html (accessed 31 January 2012).
32. Barrett B, Brown R, Mundt M, et al. (2005) Using benefit harm tradeoffs to estimate sufficiently important difference: the case of the common cold. Med Decis Making 25, 47-55.
33. de Vrese M, Winkler P, Rautenberg P, et al. (2005) Effect of Lactobacillus gasseri PA 16/8, Bifidobacterium longum SP 07/3, B. bifidum MF 20/5 on common cold episodes: a double blind, randomized, controlled trial. Clin Nutr 24, 481-491.
34. Pregliasco F, Anselmi G, Fonte L, et al. (2008) A new chance of preventing winter diseases by the administration of syn-biotic formulations. J Clin Gastroenterol 42, Suppl. 3, Pt 2, S224-S233.
35. Hatakka K. (2007). Probiotics in the prevention of clinical manifestations of common infectious diseases in children and in the elderly University of Helsinki. Academic Dissertation, 114 pp.
36. Winkler P, de VM, Laue C, et al. (2005) Effect of a dietary supplement containing probiotic bacteria plus vitamins and minerals on common cold infections and cellular immune parameters. Int J Clin Pharmacol Ther 43, 318-326.
37. Cox AJ, Pyne DB, Saunders PU, et al. (2010) Oral administration of the probiotic Lactobacillus fermentum VRI-003 and mucosal immunity in endurance athletes. Br J Sports Med 44, 222-226.
38. Tiollier E, Chennaoui M, Gomez-Merino D, et al. (2007) Effect of a probiotics supplementation on respiratory infections and immune and hormonal parameters during intense military training. Mil Med 172, 1006-1011.
39. Lavasani S, Dzhambazov B, Nouri M, et al. (2010) A novel probiotic mixture exerts a therapeutic effect on experimental autoimmune encephalomyelitis mediated by IL-10 producing regulatory T cells. PLoS One 5, e9009.
40. Tubelius P, Stan V & Zachrisson A (2005) Increasing workplace healthiness with the probiotic Lactobacillus reuteri: a randomised, double-blind placebo-controlled study. Environ Health 4, 25.
41. Bruunsgaard H, Hartkopp A, Mohr T, et al. (1997) In vivo cell-mediated immunity and vaccination response following prolonged, intense exercise. Med Sci Sports and Exer 29, 1176-1181.
42. Nieman DC (2000) Is infection risk linked to exercise workload? Med Sci Sports and Exer 32, S406-S411.
43. Nieman DC (1994) Exercise, infection, and immunity. Inter J Sports Med 15, Suppl. 3, S131-S141.
44. Husni RN, Gordon SM, Washington JA, et al. (1997) Lacto-bacillus bacteremia and endocarditis: review of 45 cases. Clin Infect Dis 25, 1048-1055.
45. Borriello SP, Hammes WP, Holzapfel W, et al. (2003) Safety of probiotics that contain lactobacilli or bifidobacteria. Clin Infect Dis 36, 775-780.
46. Antony SJ, Stratton CW & Dummer JS (1996) Lactobacillus bacteremia: description of the clinical course in adult patients without endocarditis. Clin Infect Dis 23, 773-778.
47. Rautio M, Jousimies-Somer H, Kauma H, et al. (1999) Liver abscess due to a Lactobacillus rhamnosus strain indistinguishable from L. rhamnosus strain GG. Clin Infect Dis 28, 1159-1160.
48. Salminen MK, Tynkkynen S, Rautelin H, et al. (2002) Lacto-bacillus bacteremia during a rapid increase in probiotic use of Lactobacillus rhamnosus GG in Finland. Clin Infect Dis 35, 1155-1160.
49. Besselink MG, van Santvoort HC, Buskens E, et al. (2008) Probiotic prophylaxis in predicted severe acute pancreatitis: a randomised, double-blind, placebo-controlled trial. Lancet 371, 651-659.
50. Bengmark S (2008) Is probiotic prophylaxis worthwhile in patients with predicted severe acute pancreatitis? Nat Clin Pract Gastroenterol Hepatol 5, 602-603.